Novartis will plow $700 million into a new cell-culturing facility in Singapore. The plant will boost the drug maker's capacity for biotech drugs, delivering products for commercial distribution and for clinical development. More than 300 people are expected to work there when it's complete in 2012.
It's Novartis' second big investment in Singapore manufacturing. The company just opened a new $180 million tabletting plant there today; it's expected to employ some 160 workers. Singapore was featured [1] twice [2] on our annual list [3] of the top five regions attracting biotech business.
- check out the report [4] from Channel News Asia
Related Articles:
Novartis injects $816.5M in vaccine plant. Report [5]
Singapore to spend $8B on biotech R&D. Report [6]
GSK opens $13M drug discovery lab in Singapore. Report [7]
Singapore to spend $8B on biotech R&D. Report [6]
GSK blueprints $190M vaccine plant for Singapore. Report [8]
Links:
[1] http://www.fiercebiotech.com/special-reports/top-five-regions-targeting-biotech-companies-2006
[2] http://www.fiercebiotech.com/special-reports/singapore
[3] http://www.fiercebiotech.com/special-reports/top-five-regions-targeting-biotech-companies-2007
[4] http://www.channelnewsasia.com/stories/singaporebusinessnews/view/308422/1/.html
[5] http://www.fiercepharma.com/story/novartis-injects-816-5-vaccine-plant/2007-09-07
[6] http://www.fiercebiotech.com/story/singapore-to-spend-8b-on-biotech-r-amp-d/2006-04-10
[7] http://www.fiercebiotech.com/story/gsk-opens-13m-drug-discovery-lab-in-singapore/2007-03-21
[8] http://www.fiercebiotech.com/story/gsk-blueprints-190m-vaccine-plant-for-singapore/2006-06-08